Terry Fisher
About Terry Fisher
Terry Fisher serves as the Senior Vice President of Clinical Development at Vaccinex, a position he has held since 2022. He earned his PhD in Immunology from the University of Rochester and has extensive experience in clinical science and translational research.
Work at Vaccinex
Terry Fisher currently serves as the Senior Vice President of Clinical Development at Vaccinex, a position he has held since 2022. In this role, he oversees clinical development strategies and initiatives aimed at advancing the company's therapeutic pipeline. Prior to this position, he worked as the Senior Director of Clinical & Translational Science from 2018 to 2020, and as Vice President of Clinical Science from 2020 to 2022. His extensive experience at Vaccinex highlights his commitment to the company's mission and his expertise in clinical development.
Education and Expertise
Terry Fisher earned his PhD in Immunology from the University of Rochester, where he studied from 1996 to 2002. His academic background also includes a Bachelor of Science in Biology from Cornell University, which he completed from 1990 to 1994. This educational foundation provides him with a strong understanding of biological sciences and immunological principles, which are essential for his role in clinical development.
Background
Terry Fisher has a substantial background in clinical development, particularly within the biopharmaceutical industry. His career at Vaccinex spans several key positions, allowing him to accumulate significant experience in clinical and translational science. His work has been focused on advancing therapeutic candidates through various stages of clinical trials, contributing to the company's research and development efforts.
Professional Experience
Before his current role as Senior Vice President, Terry Fisher held several important positions at Vaccinex. He served as Vice President of Clinical Science from 2020 to 2022 and as Senior Director of Clinical & Translational Science from 2018 to 2020. These roles involved leadership in clinical strategy and oversight of clinical trial operations, further establishing his expertise in the field.